Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. (CDTX): 142 pipeline candidates · ~31 mo cash runway · 58 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
31.4 months
D/E 0.23 · 0% dilution
Lead: Phase 3
142 candidates
N/A
N/A
A transparent, data-derived signal for Cidara Therapeutics, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$7.0B
Cash
$300.0M
Quarterly Burn
$40.6M
Runway
31.4 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (142 candidates)
| Drug | Phase |
|---|---|
| 0.9% sodium chloride injection | Phase 4 |
| 1000 mL of ringer's acetate solution | N/A |
| Abatacept | Phase 3 |
| Acetaminophen | Phase 3 |
| Acetaminophen 1000 mg/d | N/A |
| Acetaminophen 325Mg Tab | Phase 4 |
| Acetaminophen 4000 mg/d | N/A |
| Acetaminophen 500Mg Tab | Phase 4 |
| Acetazolamide-based medical therapy | Phase 3 |
| Acetylcysteine | Phase 2 |
Showing 10 of 142 candidates. Sign up for full pipeline.
Frequently asked questions
How many drug candidates are in Cidara Therapeutics, Inc.'s pipeline?
Cidara Therapeutics, Inc. (CDTX) has 142 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Cidara Therapeutics, Inc.'s lead drug candidate?
Cidara Therapeutics, Inc.'s most advanced tracked candidate is 0.9% sodium chloride injection (Phase 4) for Healthy Participants Study.
What is Cidara Therapeutics, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Cidara Therapeutics, Inc. has approximately 31.4 months of cash runway.
What is Cidara Therapeutics, Inc.'s market capitalization?
Cidara Therapeutics, Inc.'s market capitalization is approximately $7.0B.
Who is the CEO of Cidara Therapeutics, Inc.?
Chief Executive Officer is the chief executive officer of Cidara Therapeutics, Inc. (CDTX).
Get the full picture on Cidara Therapeutics, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.